Prophylactic removal of tubes and ovaries for women with BRCA1/2 mutations

被引：0
|
作者：
不详
机构：
来源：
REPRODUCTIVE HEALTH MATTERS | 2002年 / 10卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [21] Uptake of free BRCA1/2 testing in women at risk for BRCA1/2 germline mutations.
    Shannon, KM
    Lubratovich, ML
    Finkelstein, D
    Goggins, W
    Haber, DA
    Seiden, MV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A322 - A322
  • [22] Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations
    Schrag, D
    Kuntz, KM
    Garber, JE
    Weeks, JC
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20): : 1465 - 1471
  • [23] Prophylactic oophorectomy may differentially reduce breast cancer risk in women with BRCA1 versus BRCA2 mutations
    Angela G. Arnold
    Noah D. Kauff
    Current Breast Cancer Reports, 2009, 1 (3) : 157 - 161
  • [24] Prophylactic Oophorectomy May Differentially Reduce Breast Cancer Risk in Women With BRCA1 Versus BRCA2 Mutations
    Arnold, Angela G.
    Kauff, Noah D.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 157 - 161
  • [25] Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations
    Powell, C. Bethan
    Alabaster, Amy
    Armstrong, Mary Anne
    Stoller, Nicole
    Raine-Bennett, Tina
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 489 - 493
  • [26] BRCA1 and BRCA2 mutations in women from Shanghai China
    Suter, NM
    Ray, RM
    Hu, YW
    Lin, MG
    Porter, P
    Gao, DL
    Zaucha, RE
    Iwasaki, LM
    Sabacan, LP
    Langlois, MC
    Thomas, DB
    Ostrander, EA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 181 - 189
  • [27] Clinical management of women with genomic BRCA1 and BRCA2 mutations
    Chang, J
    Elledge, RM
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (02) : 101 - 113
  • [28] Clinical management of women with genomic BRCA1 and BRCA2 mutations*
    Jenny Chang
    Richard M. Elledge
    Breast Cancer Research and Treatment, 2001, 69 : 101 - 113
  • [29] Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations
    Powell, B.
    Alabaster, A.
    Armstrong, M. A.
    Stoller, N.
    Raine-Bennett, T. R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 201 - 201
  • [30] Risk management decisions in women with BRCA1 and BRCA2 mutations
    Morgan, Rosemary
    Brown, Audrey
    Hamman, Kelly Jo
    Sampson, Jone
    Naik, Arpana
    Massimino, Kristen
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 899 - 903
12345